64 related articles for article (PubMed ID: 12879152)
1. Selective apoptosis induction in MCF-7 cell line by truncated minimal functional region of Apoptin.
Shen Ni L; Allaudin ZN; Mohd Lila MA; Othman AM; Othman FB
BMC Cancer; 2013 Oct; 13():488. PubMed ID: 24144306
[TBL] [Abstract][Full Text] [Related]
2. Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems.
Malla WA; Arora R; Khan RIN; Mahajan S; Tiwari AK
Front Cell Dev Biol; 2020; 8():524. PubMed ID: 32671070
[TBL] [Abstract][Full Text] [Related]
3. Semisynthesis reveals apoptin as a tumour-selective protein prodrug that causes cytoskeletal collapse.
Wyatt J; Chan YK; Hess M; Tavassoli M; Müller MM
Chem Sci; 2023 Apr; 14(14):3881-3892. PubMed ID: 37035694
[TBL] [Abstract][Full Text] [Related]
4. Transducing proteins to manipulate intracellular targets.
Luft FC
J Mol Med (Berl); 2003 Sep; 81(9):521-3. PubMed ID: 12928785
[No Abstract] [Full Text] [Related]
5. The viral death effector Apoptin reveals tumor-specific processes.
Rohn JL; Noteborn MH
Apoptosis; 2004 May; 9(3):315-22. PubMed ID: 15258463
[TBL] [Abstract][Full Text] [Related]
6. Apoptin: specific killer of tumor cells?
Tavassoli M; Guelen L; Luxon BA; Gäken J
Apoptosis; 2005 Aug; 10(4):717-24. PubMed ID: 16133863
[TBL] [Abstract][Full Text] [Related]
7. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
Rutjes SA; Bosma PJ; Rohn JL; Noteborn MH; Wesseling JG
J Mol Med (Berl); 2003 Sep; 81(9):558-65. PubMed ID: 12879152
[TBL] [Abstract][Full Text] [Related]
8. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
9. The study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22.
Xue X; Huang J; Wang H
PLoS One; 2014; 9(6):e100840. PubMed ID: 24955582
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.
Wills KN; Atencio IA; Avanzini JB; Neuteboom S; Phelan A; Philopena J; Sutjipto S; Vaillancourt MT; Wen SF; Ralston RO; Johnson DE
J Virol; 2001 Sep; 75(18):8733-41. PubMed ID: 11507218
[TBL] [Abstract][Full Text] [Related]
11. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
[TBL] [Abstract][Full Text] [Related]
12. Intercellular trafficking of VP22-GFP fusion proteins.
Elliott G; O'Hare P
Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
[TBL] [Abstract][Full Text] [Related]
13. Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis.
Brewis ND; Phelan A; Normand N; Choolun E; O'Hare P
Mol Ther; 2003 Feb; 7(2):262-70. PubMed ID: 12597915
[TBL] [Abstract][Full Text] [Related]
14. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
